NO854162L - PROCEDURE FOR THE PREPARATION OF PEPTIDE-SUBSTITUTED HEAT ROCYCLIC IMMUNOSTIMULATING AGENTS. - Google Patents

PROCEDURE FOR THE PREPARATION OF PEPTIDE-SUBSTITUTED HEAT ROCYCLIC IMMUNOSTIMULATING AGENTS.

Info

Publication number
NO854162L
NO854162L NO854162A NO854162A NO854162L NO 854162 L NO854162 L NO 854162L NO 854162 A NO854162 A NO 854162A NO 854162 A NO854162 A NO 854162A NO 854162 L NO854162 L NO 854162L
Authority
NO
Norway
Prior art keywords
rocyclic
peptide
procedure
preparation
immunostimulating agents
Prior art date
Application number
NO854162A
Other languages
Norwegian (no)
Other versions
NO167923C (en
NO167923B (en
Inventor
Jeffrey Lee Ives
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO854162L publication Critical patent/NO854162L/en
Publication of NO167923B publication Critical patent/NO167923B/en
Publication of NO167923C publication Critical patent/NO167923C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO854162A 1984-10-19 1985-10-18 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PEPTID-SUBSTITUTED HETEROCYCLIC COMPOUNDS NO167923C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/662,668 US4619915A (en) 1984-10-19 1984-10-19 Peptide-substituted heterocyclic immunostimulants

Publications (3)

Publication Number Publication Date
NO854162L true NO854162L (en) 1986-04-21
NO167923B NO167923B (en) 1991-09-16
NO167923C NO167923C (en) 1991-12-27

Family

ID=24658673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854162A NO167923C (en) 1984-10-19 1985-10-18 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PEPTID-SUBSTITUTED HETEROCYCLIC COMPOUNDS

Country Status (21)

Country Link
US (1) US4619915A (en)
EP (1) EP0178845A3 (en)
JP (1) JPS61100564A (en)
KR (1) KR870000810B1 (en)
CN (1) CN85107088A (en)
AU (1) AU554078B2 (en)
CA (1) CA1277099C (en)
CS (1) CS252832B2 (en)
DD (1) DD240546A5 (en)
DK (1) DK477685A (en)
EG (1) EG17820A (en)
ES (1) ES8702433A1 (en)
FI (1) FI854074L (en)
GR (1) GR852526B (en)
HU (1) HU200783B (en)
IL (1) IL76706A0 (en)
NO (1) NO167923C (en)
NZ (1) NZ213877A (en)
PH (1) PH21389A (en)
PT (1) PT81319B (en)
ZA (1) ZA858017B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004440A1 (en) * 1986-01-23 1987-07-30 Pfizer Inc. Heptanoyl-glu-asp-ala-amino acid immunostimulants
US4888427A (en) * 1987-04-07 1989-12-19 University Of Florida Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain
US5079366A (en) * 1987-04-07 1992-01-07 University Of Florida Quarternary pyridinium salts
US4874608A (en) * 1987-04-27 1989-10-17 Imreg, Inc. Therapeutic method for treating malignancies
AU9040098A (en) * 1997-09-10 1999-03-29 University Of Florida Compounds and method for the prevention and treatment of diabetic retinopathy
US6451974B1 (en) 1999-03-17 2002-09-17 Novo Nordisk A/S Method of acylating peptides and novel acylating agents
US7273921B2 (en) * 2002-09-25 2007-09-25 Novo Nordisk A/S Method for producing acylated peptides
MXPA05012547A (en) * 2003-05-21 2006-05-25 Prosidion Ltd Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase.
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
US7869746B2 (en) 2006-03-10 2011-01-11 Ricoh Company, Ltd. Image forming device, powder supply device, and powder storage unit including a gas supplying unit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322341A (en) * 1980-05-13 1982-03-30 Fujisawa Pharmaceutical Co Peptide, process for preparation thereof and use thereof
GR81332B (en) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
GR77929B (en) * 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
CA1277099C (en) 1990-11-27
ES8702433A1 (en) 1986-12-16
FI854074L (en) 1986-04-20
CN85107088A (en) 1986-06-10
KR870000810B1 (en) 1987-04-20
NO167923C (en) 1991-12-27
IL76706A0 (en) 1986-02-28
KR860003272A (en) 1986-05-21
ES547976A0 (en) 1986-12-16
GR852526B (en) 1986-02-19
ZA858017B (en) 1987-05-27
EG17820A (en) 1991-03-30
HUT38656A (en) 1986-06-30
AU554078B2 (en) 1986-08-07
US4619915A (en) 1986-10-28
NZ213877A (en) 1988-10-28
EP0178845A3 (en) 1987-07-29
PH21389A (en) 1987-10-15
EP0178845A2 (en) 1986-04-23
JPS61100564A (en) 1986-05-19
AU4885185A (en) 1986-05-01
CS738685A2 (en) 1987-02-12
CS252832B2 (en) 1987-10-15
DK477685A (en) 1986-04-20
PT81319A (en) 1985-11-01
FI854074A0 (en) 1985-10-18
NO167923B (en) 1991-09-16
PT81319B (en) 1987-11-30
HU200783B (en) 1990-08-28
DD240546A5 (en) 1986-11-05
DK477685D0 (en) 1985-10-18

Similar Documents

Publication Publication Date Title
NO874764D0 (en) PROCEDURE FOR THE PREPARATION OF 2-AMINOPURIN DERIVATIVES.
NO821087L (en) PROCEDURE FOR THE PREPARATION OF CYCLOBUTAN DERIVATIVES.
NO822722L (en) PROCEDURE FOR THE PREPARATION OF BENZAZEPIN-2-ONER.
FI852516A0 (en) ANORDING FOR THE DOSERING OF THE TILLVAEXT BEFRAEMJANDE AEMNEN.
FI854352A0 (en) FRAMEWORK FOR THE FRAMEWORK OF RELEASE GELPARTIKLAR.
NO842273L (en) PROCEDURE FOR THE PREPARATION OF AMINOMETHYLOXOOXAZOLIDINYL BENZEN DERIVATIVES.
NO853630L (en) PROCEDURE FOR THE MANUFACTURING OF CURRENT ABSORBING PRODUCTS.
NO854162L (en) PROCEDURE FOR THE PREPARATION OF PEPTIDE-SUBSTITUTED HEAT ROCYCLIC IMMUNOSTIMULATING AGENTS.
NO155693C (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONIN DERIVATIVES.
NO855067L (en) PROCEDURE FOR THE PREPARATION OF N-FORMYL-ALFA-ASPARTYL-PHENYLALANINE.
NO853066L (en) PROCEDURE FOR THE PREPARATION OF 3-CARBONYL-1-AMINOALKYL-1H-INDOLES.
NO851920L (en) PROCEDURE FOR THE PREPARATION OF IMIDAZO-RIFAMYCIN DERIVATIVES.
NO851310L (en) STEREOSPECIFIC PROCEDURE FOR THE PREPARATION OF ACETONOXYAZETIDINON.
NO853172L (en) PROCEDURE FOR THE PREPARATION OF TIXOTROPIC DETERGENTS.
NO844137L (en) HEAT EXCHANGES AND PROCEDURES FOR PRODUCING THE SAME.
NO845071L (en) PROCEDURE FOR THE PREPARATION OF PERROMANGANE.
NO853771L (en) PROCEDURE FOR PREPARATION OF PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES.
NO830309L (en) PROCEDURE FOR THE PREPARATION OF HEATING DEVICES
FI852437A0 (en) ANORDINATION FOR THE FRAMEWORK OF TOMOGRAFIROENTGENBILDER.
NO863604D0 (en) PROCEDURE FOR THE PREPARATION OF FERROBOR Alloys.
FI823985L (en) ADJUSTMENT FOR THE PRIVATE EMPLOYMENT AV RELATIVT ENHETLIG AUTOMATISK FINAVSTAEMNINGSKAENSLIGHET
NO166709C (en) PROCEDURE FOR THE PREPARATION OF ACRYLAMIDS.
NO851319L (en) PROCEDURE FOR THE PREPARATION OF EBURNAND DERIVATIVES.
NO153456C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF ANTITUMORANTRACY LINGLUCOSIDES.
IT8224536A0 (en) PROCEDURE FOR THE PREPARATION OF MONONITROCHLOROBENZENE.